COVID-19 Impact on Global Small Interfering RNA (siRNA) Therapeutics Market Size, Status and Forecast 2020-2026

August 2020 | 97 pages | ID: C16BE5B9E70BEN
QYResearch

Abstracts

This report focuses on the global Small Interfering RNA (siRNA) Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Small Interfering RNA (siRNA) Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• GE
• Horizon Discovery
• Thermo Scientific
• OPKO Health
• AInylam Pharmaceuticals
• Arrowhead Research
• Sanofi Genzyme
• Genecon Biotechnologies
• Arbutus Biopharma
• Silent Therapeutics
• Sylentis

Market segment by Type, the product can be split into

• Liposome Based Systemic Therapy
• Nanoparticle Based Systemic Therapy
• Other

Market segment by Application, split into

• Hospital
• Research Institutions
• Pharmaceutical and Biotechnology Companies
• Academic Institutions
• Other

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Small Interfering RNA (siRNA) Therapeutics status, future forecast, growth opportunity, key market and key players.
• To present the Small Interfering RNA (siRNA) Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Small Interfering RNA (siRNA) Therapeutics are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Small Interfering RNA (siRNA) Therapeutics Revenue
1.4 Market Analysis by Type
  1.4.1 Global Small Interfering RNA (siRNA) Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Liposome Based Systemic Therapy
  1.4.3 Nanoparticle Based Systemic Therapy
  1.4.4 Other
1.5 Market by Application
  1.5.1 Global Small Interfering RNA (siRNA) Therapeutics Market Share by Application: 2020 VS 2026
  1.5.2 Hospital
  1.5.3 Research Institutions
  1.5.4 Pharmaceutical and Biotechnology Companies
  1.5.5 Academic Institutions
  1.5.6 Other
1.6 Coronavirus Disease 2019 (Covid-19): Small Interfering RNA (siRNA) Therapeutics Industry Impact
  1.6.1 How the Covid-19 is Affecting the Small Interfering RNA (siRNA) Therapeutics Industry
    1.6.1.1 Small Interfering RNA (siRNA) Therapeutics Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Small Interfering RNA (siRNA) Therapeutics Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Small Interfering RNA (siRNA) Therapeutics Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Small Interfering RNA (siRNA) Therapeutics Market Perspective (2015-2026)
2.2 Small Interfering RNA (siRNA) Therapeutics Growth Trends by Regions
  2.2.1 Small Interfering RNA (siRNA) Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Small Interfering RNA (siRNA) Therapeutics Historic Market Share by Regions (2015-2020)
  2.2.3 Small Interfering RNA (siRNA) Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Small Interfering RNA (siRNA) Therapeutics Market Growth Strategy
  2.3.6 Primary Interviews with Key Small Interfering RNA (siRNA) Therapeutics Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Small Interfering RNA (siRNA) Therapeutics Players by Market Size
  3.1.1 Global Top Small Interfering RNA (siRNA) Therapeutics Players by Revenue (2015-2020)
  3.1.2 Global Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by Players (2015-2020)
  3.1.3 Global Small Interfering RNA (siRNA) Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Small Interfering RNA (siRNA) Therapeutics Market Concentration Ratio
  3.2.1 Global Small Interfering RNA (siRNA) Therapeutics Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Small Interfering RNA (siRNA) Therapeutics Revenue in 2019
3.3 Small Interfering RNA (siRNA) Therapeutics Key Players Head office and Area Served
3.4 Key Players Small Interfering RNA (siRNA) Therapeutics Product Solution and Service
3.5 Date of Enter into Small Interfering RNA (siRNA) Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Small Interfering RNA (siRNA) Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Small Interfering RNA (siRNA) Therapeutics Forecasted Market Size by Type (2021-2026)

5 SMALL INTERFERING RNA (SIRNA) THERAPEUTICS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2015-2020)
5.2 Global Small Interfering RNA (siRNA) Therapeutics Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Small Interfering RNA (siRNA) Therapeutics Market Size (2015-2020)
6.2 Small Interfering RNA (siRNA) Therapeutics Key Players in North America (2019-2020)
6.3 North America Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2015-2020)
6.4 North America Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Small Interfering RNA (siRNA) Therapeutics Market Size (2015-2020)
7.2 Small Interfering RNA (siRNA) Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2015-2020)
7.4 Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2015-2020)

8 CHINA

8.1 China Small Interfering RNA (siRNA) Therapeutics Market Size (2015-2020)
8.2 Small Interfering RNA (siRNA) Therapeutics Key Players in China (2019-2020)
8.3 China Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2015-2020)
8.4 China Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Small Interfering RNA (siRNA) Therapeutics Market Size (2015-2020)
9.2 Small Interfering RNA (siRNA) Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2015-2020)
9.4 Japan Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Small Interfering RNA (siRNA) Therapeutics Market Size (2015-2020)
10.2 Small Interfering RNA (siRNA) Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2015-2020)

11 INDIA

11.1 India Small Interfering RNA (siRNA) Therapeutics Market Size (2015-2020)
11.2 Small Interfering RNA (siRNA) Therapeutics Key Players in India (2019-2020)
11.3 India Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2015-2020)
11.4 India Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Small Interfering RNA (siRNA) Therapeutics Market Size (2015-2020)
12.2 Small Interfering RNA (siRNA) Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 GE
  13.1.1 GE Company Details
  13.1.2 GE Business Overview and Its Total Revenue
  13.1.3 GE Small Interfering RNA (siRNA) Therapeutics Introduction
  13.1.4 GE Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2015-2020))
  13.1.5 GE Recent Development
13.2 Horizon Discovery
  13.2.1 Horizon Discovery Company Details
  13.2.2 Horizon Discovery Business Overview and Its Total Revenue
  13.2.3 Horizon Discovery Small Interfering RNA (siRNA) Therapeutics Introduction
  13.2.4 Horizon Discovery Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2015-2020)
  13.2.5 Horizon Discovery Recent Development
13.3 Thermo Scientific
  13.3.1 Thermo Scientific Company Details
  13.3.2 Thermo Scientific Business Overview and Its Total Revenue
  13.3.3 Thermo Scientific Small Interfering RNA (siRNA) Therapeutics Introduction
  13.3.4 Thermo Scientific Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2015-2020)
  13.3.5 Thermo Scientific Recent Development
13.4 OPKO Health
  13.4.1 OPKO Health Company Details
  13.4.2 OPKO Health Business Overview and Its Total Revenue
  13.4.3 OPKO Health Small Interfering RNA (siRNA) Therapeutics Introduction
  13.4.4 OPKO Health Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2015-2020)
  13.4.5 OPKO Health Recent Development
13.5 AInylam Pharmaceuticals
  13.5.1 AInylam Pharmaceuticals Company Details
  13.5.2 AInylam Pharmaceuticals Business Overview and Its Total Revenue
  13.5.3 AInylam Pharmaceuticals Small Interfering RNA (siRNA) Therapeutics Introduction
  13.5.4 AInylam Pharmaceuticals Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2015-2020)
  13.5.5 AInylam Pharmaceuticals Recent Development
13.6 Arrowhead Research
  13.6.1 Arrowhead Research Company Details
  13.6.2 Arrowhead Research Business Overview and Its Total Revenue
  13.6.3 Arrowhead Research Small Interfering RNA (siRNA) Therapeutics Introduction
  13.6.4 Arrowhead Research Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2015-2020)
  13.6.5 Arrowhead Research Recent Development
13.7 Sanofi Genzyme
  13.7.1 Sanofi Genzyme Company Details
  13.7.2 Sanofi Genzyme Business Overview and Its Total Revenue
  13.7.3 Sanofi Genzyme Small Interfering RNA (siRNA) Therapeutics Introduction
  13.7.4 Sanofi Genzyme Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2015-2020)
  13.7.5 Sanofi Genzyme Recent Development
13.8 Genecon Biotechnologies
  13.8.1 Genecon Biotechnologies Company Details
  13.8.2 Genecon Biotechnologies Business Overview and Its Total Revenue
  13.8.3 Genecon Biotechnologies Small Interfering RNA (siRNA) Therapeutics Introduction
  13.8.4 Genecon Biotechnologies Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2015-2020)
  13.8.5 Genecon Biotechnologies Recent Development
13.9 Arbutus Biopharma
  13.9.1 Arbutus Biopharma Company Details
  13.9.2 Arbutus Biopharma Business Overview and Its Total Revenue
  13.9.3 Arbutus Biopharma Small Interfering RNA (siRNA) Therapeutics Introduction
  13.9.4 Arbutus Biopharma Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2015-2020)
  13.9.5 Arbutus Biopharma Recent Development
13.10 Silent Therapeutics
  13.10.1 Silent Therapeutics Company Details
  13.10.2 Silent Therapeutics Business Overview and Its Total Revenue
  13.10.3 Silent Therapeutics Small Interfering RNA (siRNA) Therapeutics Introduction
  13.10.4 Silent Therapeutics Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2015-2020)
  13.10.5 Silent Therapeutics Recent Development
13.11 Sylentis
  10.11.1 Sylentis Company Details
  10.11.2 Sylentis Business Overview and Its Total Revenue
  10.11.3 Sylentis Small Interfering RNA (siRNA) Therapeutics Introduction
  10.11.4 Sylentis Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2015-2020)
  10.11.5 Sylentis Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Small Interfering RNA (siRNA) Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Small Interfering RNA (siRNA) Therapeutics Revenue
Table 3. Ranking of Global Top Small Interfering RNA (siRNA) Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Small Interfering RNA (siRNA) Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Liposome Based Systemic Therapy
Table 6. Key Players of Nanoparticle Based Systemic Therapy
Table 7. Key Players of Other
Table 8. COVID-19 Impact Global Market: (Four Small Interfering RNA (siRNA) Therapeutics Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Small Interfering RNA (siRNA) Therapeutics Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Small Interfering RNA (siRNA) Therapeutics Players to Combat Covid-19 Impact
Table 13. Global Small Interfering RNA (siRNA) Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Small Interfering RNA (siRNA) Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Small Interfering RNA (siRNA) Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Small Interfering RNA (siRNA) Therapeutics Market Share by Regions (2015-2020)
Table 17. Global Small Interfering RNA (siRNA) Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Small Interfering RNA (siRNA) Therapeutics Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Small Interfering RNA (siRNA) Therapeutics Market Growth Strategy
Table 23. Main Points Interviewed from Key Small Interfering RNA (siRNA) Therapeutics Players
Table 24. Global Small Interfering RNA (siRNA) Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 25. Global Small Interfering RNA (siRNA) Therapeutics Market Share by Players (2015-2020)
Table 26. Global Top Small Interfering RNA (siRNA) Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Small Interfering RNA (siRNA) Therapeutics as of 2019)
Table 27. Global Small Interfering RNA (siRNA) Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Small Interfering RNA (siRNA) Therapeutics Product Solution and Service
Table 30. Date of Enter into Small Interfering RNA (siRNA) Therapeutics Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 33. Global Small Interfering RNA (siRNA) Therapeutics Market Size Share by Type (2015-2020)
Table 34. Global Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by Type (2021-2026)
Table 35. Global Small Interfering RNA (siRNA) Therapeutics Market Size Share by Application (2015-2020)
Table 36. Global Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 37. Global Small Interfering RNA (siRNA) Therapeutics Market Size Share by Application (2021-2026)
Table 38. North America Key Players Small Interfering RNA (siRNA) Therapeutics Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Small Interfering RNA (siRNA) Therapeutics Market Share (2019-2020)
Table 40. North America Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 41. North America Small Interfering RNA (siRNA) Therapeutics Market Share by Type (2015-2020)
Table 42. North America Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 43. North America Small Interfering RNA (siRNA) Therapeutics Market Share by Application (2015-2020)
Table 44. Europe Key Players Small Interfering RNA (siRNA) Therapeutics Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Small Interfering RNA (siRNA) Therapeutics Market Share (2019-2020)
Table 46. Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Small Interfering RNA (siRNA) Therapeutics Market Share by Type (2015-2020)
Table 48. Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Small Interfering RNA (siRNA) Therapeutics Market Share by Application (2015-2020)
Table 50. China Key Players Small Interfering RNA (siRNA) Therapeutics Revenue (2019-2020) (Million US$)
Table 51. China Key Players Small Interfering RNA (siRNA) Therapeutics Market Share (2019-2020)
Table 52. China Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 53. China Small Interfering RNA (siRNA) Therapeutics Market Share by Type (2015-2020)
Table 54. China Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 55. China Small Interfering RNA (siRNA) Therapeutics Market Share by Application (2015-2020)
Table 56. Japan Key Players Small Interfering RNA (siRNA) Therapeutics Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Small Interfering RNA (siRNA) Therapeutics Market Share (2019-2020)
Table 58. Japan Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Small Interfering RNA (siRNA) Therapeutics Market Share by Type (2015-2020)
Table 60. Japan Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Small Interfering RNA (siRNA) Therapeutics Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Small Interfering RNA (siRNA) Therapeutics Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Small Interfering RNA (siRNA) Therapeutics Market Share (2019-2020)
Table 64. Southeast Asia Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Small Interfering RNA (siRNA) Therapeutics Market Share by Type (2015-2020)
Table 66. Southeast Asia Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Small Interfering RNA (siRNA) Therapeutics Market Share by Application (2015-2020)
Table 68. India Key Players Small Interfering RNA (siRNA) Therapeutics Revenue (2019-2020) (Million US$)
Table 69. India Key Players Small Interfering RNA (siRNA) Therapeutics Market Share (2019-2020)
Table 70. India Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 71. India Small Interfering RNA (siRNA) Therapeutics Market Share by Type (2015-2020)
Table 72. India Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 73. India Small Interfering RNA (siRNA) Therapeutics Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Small Interfering RNA (siRNA) Therapeutics Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Small Interfering RNA (siRNA) Therapeutics Market Share (2019-2020)
Table 76. Central & South America Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Small Interfering RNA (siRNA) Therapeutics Market Share by Type (2015-2020)
Table 78. Central & South America Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Small Interfering RNA (siRNA) Therapeutics Market Share by Application (2015-2020)
Table 80. GE Company Details
Table 81. GE Business Overview
Table 82. GE Product
Table 83. GE Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2015-2020) (Million US$)
Table 84. GE Recent Development
Table 85. Horizon Discovery Company Details
Table 86. Horizon Discovery Business Overview
Table 87. Horizon Discovery Product
Table 88. Horizon Discovery Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2015-2020) (Million US$)
Table 89. Horizon Discovery Recent Development
Table 90. Thermo Scientific Company Details
Table 91. Thermo Scientific Business Overview
Table 92. Thermo Scientific Product
Table 93. Thermo Scientific Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2015-2020) (Million US$)
Table 94. Thermo Scientific Recent Development
Table 95. OPKO Health Company Details
Table 96. OPKO Health Business Overview
Table 97. OPKO Health Product
Table 98. OPKO Health Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2015-2020) (Million US$)
Table 99. OPKO Health Recent Development
Table 100. AInylam Pharmaceuticals Company Details
Table 101. AInylam Pharmaceuticals Business Overview
Table 102. AInylam Pharmaceuticals Product
Table 103. AInylam Pharmaceuticals Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2015-2020) (Million US$)
Table 104. AInylam Pharmaceuticals Recent Development
Table 105. Arrowhead Research Company Details
Table 106. Arrowhead Research Business Overview
Table 107. Arrowhead Research Product
Table 108. Arrowhead Research Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2015-2020) (Million US$)
Table 109. Arrowhead Research Recent Development
Table 110. Sanofi Genzyme Company Details
Table 111. Sanofi Genzyme Business Overview
Table 112. Sanofi Genzyme Product
Table 113. Sanofi Genzyme Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2015-2020) (Million US$)
Table 114. Sanofi Genzyme Recent Development
Table 115. Genecon Biotechnologies Business Overview
Table 116. Genecon Biotechnologies Product
Table 117. Genecon Biotechnologies Company Details
Table 118. Genecon Biotechnologies Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2015-2020) (Million US$)
Table 119. Genecon Biotechnologies Recent Development
Table 120. Arbutus Biopharma Company Details
Table 121. Arbutus Biopharma Business Overview
Table 122. Arbutus Biopharma Product
Table 123. Arbutus Biopharma Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2015-2020) (Million US$)
Table 124. Arbutus Biopharma Recent Development
Table 125. Silent Therapeutics Company Details
Table 126. Silent Therapeutics Business Overview
Table 127. Silent Therapeutics Product
Table 128. Silent Therapeutics Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2015-2020) (Million US$)
Table 129. Silent Therapeutics Recent Development
Table 130. Sylentis Company Details
Table 131. Sylentis Business Overview
Table 132. Sylentis Product
Table 133. Sylentis Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2015-2020) (Million US$)
Table 134. Sylentis Recent Development
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Small Interfering RNA (siRNA) Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Liposome Based Systemic Therapy Features
Figure 3. Nanoparticle Based Systemic Therapy Features
Figure 4. Other Features
Figure 5. Global Small Interfering RNA (siRNA) Therapeutics Market Share by Application: 2020 VS 2026
Figure 6. Hospital Case Studies
Figure 7. Research Institutions Case Studies
Figure 8. Pharmaceutical and Biotechnology Companies Case Studies
Figure 9. Academic Institutions Case Studies
Figure 10. Other Case Studies
Figure 11. Small Interfering RNA (siRNA) Therapeutics Report Years Considered
Figure 12. Global Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Small Interfering RNA (siRNA) Therapeutics Market Share by Regions: 2020 VS 2026
Figure 14. Global Small Interfering RNA (siRNA) Therapeutics Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Small Interfering RNA (siRNA) Therapeutics Market Share by Players in 2019
Figure 17. Global Top Small Interfering RNA (siRNA) Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Small Interfering RNA (siRNA) Therapeutics as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Small Interfering RNA (siRNA) Therapeutics Revenue in 2019
Figure 19. North America Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. GE Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. GE Revenue Growth Rate in Small Interfering RNA (siRNA) Therapeutics Business (2015-2020)
Figure 28. Horizon Discovery Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Horizon Discovery Revenue Growth Rate in Small Interfering RNA (siRNA) Therapeutics Business (2015-2020)
Figure 30. Thermo Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Thermo Scientific Revenue Growth Rate in Small Interfering RNA (siRNA) Therapeutics Business (2015-2020)
Figure 32. OPKO Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. OPKO Health Revenue Growth Rate in Small Interfering RNA (siRNA) Therapeutics Business (2015-2020)
Figure 34. AInylam Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. AInylam Pharmaceuticals Revenue Growth Rate in Small Interfering RNA (siRNA) Therapeutics Business (2015-2020)
Figure 36. Arrowhead Research Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Arrowhead Research Revenue Growth Rate in Small Interfering RNA (siRNA) Therapeutics Business (2015-2020)
Figure 38. Sanofi Genzyme Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Sanofi Genzyme Revenue Growth Rate in Small Interfering RNA (siRNA) Therapeutics Business (2015-2020)
Figure 40. Genecon Biotechnologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Genecon Biotechnologies Revenue Growth Rate in Small Interfering RNA (siRNA) Therapeutics Business (2015-2020)
Figure 42. Arbutus Biopharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Arbutus Biopharma Revenue Growth Rate in Small Interfering RNA (siRNA) Therapeutics Business (2015-2020)
Figure 44. Silent Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Silent Therapeutics Revenue Growth Rate in Small Interfering RNA (siRNA) Therapeutics Business (2015-2020)
Figure 46. Sylentis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Sylentis Revenue Growth Rate in Small Interfering RNA (siRNA) Therapeutics Business (2015-2020)
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed